SSSimone Garruth dos Santos Machado Sampaio

Simone Garruth dos Santos Machado Sampaio

*This is an algorithmically generated author record based on publicly available information.

Simone Garruth dos Santos Machado Sampaio has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Morfina tópica para pacientes com feridas neoplásicas dolorosas: protocolo de ensaio clínico

    by Daianny Arrais de Oliveira da Cunha, Patrícia dos Santos Claro Fuly, Alex Sandro De Azeredo Siqueira, Fernanda Barcellos Santiago, Helen Balthazar De Lima, Raquel De Souza Soares, Rayanne Bandeira Carneiro, Simone Garruth dos Santos Machado Sampaio

    Objective: To analyze the effectiveness of topical morphine in controlling local pain and promoting comfort in patients with neoplastic wounds in the breast, head, or neck. Method: A randomized, double-blind, phase II clinical trial conducted in a single center. The study aims to include 106 patients with malignant neoplastic wounds in these regions, over 18 years of age, with a minimum score of three on the numerical pain assessment scale (0-10). Expected results: The main outcomes evaluated will be average pain intensity, average pain relief, comfort score, systemic morphine dosage, and incidence/classification of adverse events.Registration: ClinicalTrials.gov (NCT05800834).

  • Open Access

    Assessment of pain control in advanced cancer patients admitted to a palliative care unit

    by Marcela Amitrano Bilobran, Maria Fernanda Fernandes Duarte Costa, Andrezza Regadas Muniz, Patrícia Almeida Chelles, Edson Tavares da Silva Neto, Livia Costa de Oliveira, Simone Garruth dos Santos Machado Sampaio

    Introduction: Pain in people with cancer is prevalent and should have an individualized therapeutic plan. Objectives: To evaluate pain control in advanced cancer patients in a hospital palliative care unit. Methods: This is a cohort study, with prospective design, and quantitative approach, including advanced cancer patients admitted to a palliative care unit between June 2021 and February 2022 reporting pain. Data was collected from medical records and the Brief Pain Inventory (BPI) was used to assess pain on the first (D1), third (D3) and seventh (D7) day of hospitalization. Results: One hundred and four patients participated in the study. The most prevalent tumors were of the gastrointestinal tract (n=23; 22%), cervix (n=21; 20%) and breast (n=17; 16%). Abdomen was the most reported site of pain (n=34; 33%), with 50% classified as nociceptive pain, 39% neuropathic pain, and 11% mixed. On D1, 43% reported severe pain, 31% moderate, and 12% mild pain. There was an evolutionary drop in the percentage of severe pain (BPI3 70% to 37.1%; BPI4 12.6% to 5.4%; BPI5 42.5% to 13.5%; and BPI9 67.8% to 21.6%) according to the answers to all BPI questions during the period. On D1, D3 and D7, the average equipotent doses of oral morphine were 116 mg, 133 mg and 154 mg and the frequency of use of adjuvant use was 60%, 75%, and 69%, respectively. Conclusions: Pain was properly controlled and was related to the increased use of adjuvants, both for general and neuropathic pain. It was possible to observe that the use of adjuvants was related to better pain control.

  • Open Access

    Factors Associated with Neuropathic Pain in Cancer Patients Admitted to a Palliative Care Unit

    by Patricia Almeida Chelles, Livia Costa de Oliveira, Luciana Silva Couto, Simone Garruth dos Santos Machado Sampaio, Anke Bergmann

    Introduction: Recognizing factors associated with pain in advanced cancer patients may favor a better multidisciplinary approach. Objective: To identify factors associated with the most prevalent type of pain in cancer patients admitted to a palliative care unit. Method: Cohort-study-based cross-sectional analysis of baseline data collected from cancer inpatients at the palliative care unit assisted by the physiotherapy service. Sociodemographic, clinical data and pain characteristics were obtained and analyzed according to the most prevalent type of pain at hospital admission. An odds ratio (OR) logistic regression was utilized as a measure of effect at a 95% confidenceinterval (95% CI). Results: A total of 62 patients were assessed, mostly women (69.3%) with less than 60 years old (67.7%), the most frequent tumor sites were gynecological (25.8%) and breast (16.1%). Local disease progression associated with metastasis was observed in 87.1% of all patients, with 50.0% presenting bone metastasis and 37.1%, a bone event. The most prevalent type was moderate tosevere (69.3%) neuropathic pain (51.6%), associated with the presence of a bone event (OR = 3.16; 95% CI: 1.01-9.90) and less than 60 years old (OR = 4.08; 95% CI: 1.91 -17.52). Conclusion: Neuropathic pain was the most prevalent pain in cancer patients receiving palliative care associated with the presence of bone events and less than 60 years old. Introducción: Reconocer los factores asociados al dolor en pacientes con cáncer avanzado puede favorecer un mejor abordaje multidisciplinario. Objetivo: Identificar los factores asociados al tipo de dolor más prevalente en pacientes oncológicos ingresados en una unidad de cuidados paliativos. Método: Análisis transversal basado en un estudio de cohorte de datos basales recopilados de pacientes oncológicos ingresados en la unidad de cuidados paliativos atendidos por el servicio de fisioterapia. Datos sociodemográficos, clínicos y características del dolor según el tipo de dolor más prevalente al ingreso hospitalario. Se utilizó una regresión logística empleando el odds ratio (OR) como medida del efecto en un intervalo de confianza del 95% (IC del 95%). Resultados: Se evaluaron 62 pacientes, la mayoría del sexo femenino (69,3%), menores de 60 años (67,7%), y los tumores más frecuentes fueron ginecológicos (25,8%) y de mama (16,1%). Se observó progresión local de la enfermedad asociada con metástasis en el 87,1% de todos los pacientes, el 50,0% tuvo metástasis óseas y el 37,1% tuvo un evento óseo. El tipo de dolor más prevalente fue el neuropático (51,6%), moderado a severo (69,3%). El dolor neuropático se asoció con la presencia de evento óseo (OR = 3,16; IC 95%: 1,01-9,90) y edad menor de 60 años (OR = 4,08; IC 95%: 1,91-17,52). Conclusión: El dolor neuropático fue el dolor más prevalente en pacientes oncológicos sometidos a cuidados paliativos asociado a la presencia de eventos óseos y edad menor de 60 años. Introdução: Reconhecer os fatores associados à dor em pacientes com câncer avançado pode favorecer uma melhor abordagem multidisciplinar. Objetivo: Identificar os fatores associados ao tipo de dor mais prevalente em pacientes oncológicos internados em uma unidade de cuidados paliativos. Método: Análise transversal baseada em estudo de coorte de dados basais coletados de pacientes oncológicos internados na unidade de cuidados paliativos atendidos pelo serviço de fisioterapia. Dados sociodemográficos, clínicos e características da dor foram obtidos e analisados de acordo com o tipo de dor mais prevalente na admissão hospitalar. Uma regressão logística empregando o odds ratio (OR) foi utilizada como medida de efeito em um intervalo de confiança de 95% (IC 95%). Resultados: Foram avaliados 62 pacientes, a maioria do sexo feminino (69,3%), com idade inferior a 60 anos (67,7%), e os tumores mais frequentes foram os ginecológicos (25,8%) e mamários (16,1%). A progressão local da doença associada à metástase foi observada em 87,1% de todos os pacientes, 50,0% apresentaram metástase óssea e 37,1%, evento ósseo. O tipo de dor mais prevalente foi a neuropática (51,6%), moderada a intensa (69,3%). A dor neuropática foi associada à presença de evento ósseo (OR = 3,16; IC 95%: 1,01-9,90) e idade inferior a 60 anos (OR = 4,08; IC 95%: 1,91-17,52). Conclusão: A dor neuropática foi a mais prevalente em pacientes oncológicos em cuidados paliativos associada à presença de eventos ósseos e idade inferior a 60 anos.


  • Pain management effectiveness in advanced cancer: palliative care unit inpatient study

    by Simone Garruth dos Santos Machado Sampaio, Maria Fernanda Fernandes Duarte Costa, Marcela Amitrano Bilobran, Andrezza Helena Regadas Muniz, Patrícia Almeida Chelles, Julia Werneck Paulino Soares Souza, Livia Costa de Oliveira

    Objectives The aim of this study is to evaluate pain management adequacy based on the Pain Management Index (PMI), and its association with the Brief Pain Inventory (BPI) in advanced cancer inpatients to a palliative care unit. Methods This is a quantitative study concerning advanced cancer inpatients in a specialised palliative care unit between June 2021 and February 2022. The BPI was applied, and analgesia was observed on the first (D1), third (D3) and seventh (D7) day of hospitalisation. Adequate analgesia was considered when PMI≥0. Results A total of 104 patients were evaluated on D1, 68 on D3 and 45 on D7, with a mean age of 53.6 years (SD±14.1), most of them female (65.4%), with the most frequent primary tumour site located in the gastrointestinal tract (22.1%). The observed analgesia was adequate (PMI≥0) in 52.9% of all patients on D1, 95.6% on D3 and 100% on D7 (p value=0.012). The number of patients with moderate to severe pain interference in general activities (p value 0.012), mood (p value 0.014), walking ability (p value 0.047), normal work (p value 0.038) and pleasure of living (p value 0.025) decreased during hospitalisation. Conclusions Pain is a prevalent and impacting symptom in patients undergoing palliative care. Thus, objective analgesic adequacy assessments in specialised services are required. These findings reinforce the importance of effective pain control and corroborate the importance of employing objective tools in evaluating medical services and improving quality of life of patients.


  • Open Access

    Construção de um Guia para Avaliação e Manejo Fisioterapêutico da Dor em Pacientes com Câncer

    by Patricia Almeida Chelles, Livia Costa de Oliveira, Luciana Silva Couto, Simone Garruth dos Santos Machado Sampaio, Fernando Lopes Tavares de Lima, Anke Bergmann

    Introdução: A fisioterapia pode contribuir para o controle da dor em pacientes com câncer e estratégias educativas devem ser desenvolvidas para aumentar as ações fisioterapêuticas nesse contexto. Objetivo: Elaborar um guia para avaliação e manejo fisioterapêutico da dor no câncer. Método: Estudo desenvolvido em três etapas: 1. Análise descritiva de dados sociodemográficos, clínicos, funcionais, características da dor e tratamentos fisioterapêuticos realizados em pacientes com câncer em cuidados paliativos; 2. Desenvolvimento da versão preliminar do guia a partir dos resultados da primeira etapa e de conteúdo teórico na temática; 3. Realização de grupo focal composto por fisioterapeutas que originou a versão final do guia. Resultados: Foram incluídos 62 pacientes, principalmente do sexo feminino (69,3%). O sítio tumoral mais frequente foi o ginecológico (25,8%) e metade apresentou metástase óssea. O tipo de dor mais prevalente foi a neuropática (51,6%), localizada na coluna (29,0%). Os tratamentos fisioterapêuticos mais utilizados foram: posicionamento (98,0%), cinesioterapia (68,0%), deambulação (39,0%), uso de órteses (32,0%) e transcutaneous electrical nerve stimulation (21,0%). O grupo focal sugeriu alterações e avaliou positivamente a versão preliminar do guia, ressaltando que, além de ser elaborado com linguagem de fácil compreensão, possibilitou a visão integral sobre os métodos para avaliação e tratamento fisioterapêutico da dor. Conclusão: O conhecimento das caraterísticas dos pacientes, associado aos dados de literatura e à participação de profissionais especialistas, possibilitou a construção de um guia que foi desenvolvido para ser objetivo e de fácil compreensão para fisioterapeutas, contendo diversos recursos para avaliação e manejo fisioterapêutico da dor em pacientes com câncer.


  • Correlation Between Cancer Pain and Quality of Life in Patients With Advanced Cancer Admitted to a Palliative Care Unit

    by Maria Fernanda Fernandes Duarte Costa, Marcela Amitrano Bilobran, Livia Costa de Oliveira, Andrezza Helena Regadas Muniz, Patricia Almeida Chelles, Simone Garruth dos Santos Machado Sampaio

    Introduction: Cancer pain is one of the most prevalent manageable symptoms in patients with advanced cancer, and it has a negative impact on quality of life (QoL). Objective: The aim of this study is to examine the correlation between cancer pain and QoL in patients with advanced cancer who are hospitalized in a palliative care unit. Methods: This study is a cross-sectional analysis of patients with advanced cancer who were hospitalized with cancer pain at a specialized palliative care unit between June 2021 and February 2022. Pain intensity and its impact on daily activities were assessed using the Brief Pain Inventory (BPI), while the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 15 PAL (QLQ-C15-PAL) was used to evaluate QoL. Results: A total of 104 patients with cancer pain were included, with a mean age of 53.6 years (±14.1). Most of the patients were female (65.38%), and the most common primary tumor site was in the gastrointestinal tract (22.11%). The most frequently reported site of cancer pain was the abdomen (32.69%). The mean duration of cancer pain was 52.3 days (±6.2). The domains of QoL most strongly correlated with cancer pain were weakness (coefficient = .52, P < .001), nausea (coefficient = .36, P < .001), and the physical domain (coefficient = -.30, P < .001). Conclusion: Cancer pain is strongly correlated with a deterioration in QoL in patients with advanced cancer, and its management should be pursued as a strategy for optimizing QoL.


  • Open Access

    Telemedicina em Cuidados Paliativos Oncológicos: um Legado da Pandemia

    by Cristhiane da Silva Pinto, Alessandra Zanei Borsatto, Danielle Copello Vaz, Simone Garruth dos Santos Machado Sampaio, Livia Costa de Oliveira

    Introdução: A telemedicina pode ser um instrumento útil para o acompanhamento de pacientes em cuidados paliativos, especialmente no contexto da pandemia por covid-19. Objetivo: Descrever o uso da telemedicina para pacientes em cuidados paliativos oncológicos acompanhados ambulatorialmente em uma unidade de referência nacional. Método: Análise retrospectiva de teleatendimentos médicos realizados entre abril de 2020 e fevereiro de 2021 a pacientes da unidade acompanhados ambulatorialmente. Foram analisados dados demográficos e clínicos dos pacientes, características do teleatendimento e conduta médica, e feita uma avaliação subjetiva com os profissionais responsáveis pelos teleatendimentos. Resultados: Foram realizados 1.645 teleatendimentos médicos a 470 pacientes com idade média de 62 (54-73) anos, sendo a maioria do sexo feminino (n=258; 54,9%) e com Karnofsky Performance Status estimado em 40% ou superior (n=423; 90,0%) no momento do primeiro contato a distância. Os teleatendimentos foram realizados, em sua maior parte (n=928; 56,4%), para o monitoramento da carga de sintomas entre as consultas presenciais. Destes, em 612 (frequência relativa=65,9%), houve sintoma controlado no teleatendimento subsequente. A queixa mais prevalente foi dor (n=303; frequência relativa=32,7%) seguida por sintomas gripais (n=108; frequência relativa=11,6%). Entre as condutas traçadas, a mais prevalente (n=921; 56,0%) foi o comparecimento apenas do responsável pela retirada dos medicamentos, sem necessidade de deslocamento do paciente. Conclusão: A telemedicina mostrou-se útil na monitorização de sintomas de pacientes com câncer avançado e permitiu que pacientes e cuidadores se mantivessem em seus domicílios, reduzindo o deslocamento e, consequentemente, o risco de contágio por covid-19.


  • Open Access

    Fatores Associados ao Karnofsky Performance Status e sua Trajetória no Último Mês de Vida em Pacientes com Câncer Terminal

    by Andrezza Helena Regadas Muniz, Karla Santos da Costa Rosa, Juliana Miranda Dutra de Resende, Simone Garruth dos Santos Machado Sampaio, Livia Costa de Oliveira

    Introdução: O Karnofsky Performance Status (KPS) pode caracterizar o impacto da doença em pacientes com câncer. Objetivo: Avaliar os fatores associados ao KPS e a sua trajetória no último mês de vida em pacientes com câncer terminal. Método: Estudo de coorte retrospectivo, com pacientes com câncer terminal internados em uma unidade de cuidados paliativos, falecidos entre julho e agosto de 2019. A variável dependente foi o KPS avaliado diariamente no último mês de vida. Uma análise transversal dos fatores associados ao KPS inicial foi realizada por meio de regressões logísticas ordinais. Para verificar a trajetória do KPS no último mês de vida, foram realizadas análises gráficas longitudinais. Resultados: Foram avaliados 108 pacientes, cuja maioria possuía >60 anos (68,5%) e era do sexo feminino (62,0%). Os sítios tumorais mais prevalentes foram o trato gastrointestinal (TGI) (24,3%), mama (18,7%) e cabeça e pescoço (CP) (16,8%). No modelo múltiplo, os sítios tumorais primários permaneceram associados ao KPS. Durante o último mês de vida, a redução do KPS foi mais pronunciada naqueles com tumor no TGI, CP e tecido ósseo conjuntivo, que apresentaram valores mais elevados de KPS no trigésimo dia antes do óbito quando comparados aos demais. Por outro lado, aqueles com câncer no sistema nervoso central e pulmão iniciaram o período de seguimento com valores de KPS mais baixos e tiveram redução menos exacerbada que os demais. Conclusão: Os valores de KPS diminuem no último mês de vida, porém com intensidade diferente de acordo com o local do tumor em pacientes com câncer terminal.

  • Open Access

    Palliative Care and COVID-19 Pandemic: Retrospective Study of Factors Associated With Infection and Death at an Oncological Palliative Care Reference Center

    by Livia Costa de Oliveira, Karla Santos da Costa Rosa, Ana Luísa Durante, Luciana de Oliveira Ramadas Rodrigues, Daianny Arrais de Oliveira da Cunha, Luciana Aparecida Faria de Oliveira, Renata de Freitas, Alessandra Zanei Borsatto, Eliza Maffioletti Furtunato Leocádio Esteves, Simone Garruth dos Santos Machado Sampaio

    Background: Advanced cancer patients are part of a group likely to be more susceptible to COVID-19. Aims: To describe the profile of advanced cancer inpatients to an exclusive Palliative Care Unit (PCU) with the diagnosis of COVID-19, and to evaluate the factors associated with death in these cases. Design: Retrospective cohort study with data from advanced cancer inpatients to an exclusive PCU, from March to July 2020, with severe acute respiratory syndrome. Diagnostic of COVID-19 and death were the dependent variables. Logistic regression analyses were performed, with the odds ratio (OR) and 95% confidence interval (CI). Results: One hundred fifty-five patients were selected. The mean age was 60.9 (±13.4) years old and the most prevalent tumor type was breast (30.3%). Eighty-three (53.5%) patients had a diagnostic confirmation of COVID-19. Having diabetes mellitus (OR: 2.2; 95% CI: 1.1-6.6) and having received chemotherapy in less than 30 days before admission (OR: 3.8; 95% CI: 1.2-12.2) were associated factors to diagnosis of COVID-19. Among those infected, 81.9% died and, patients with Karnofsky Performance Status (KPS) < 30% (OR: 14.8; 95% CI 2.7-21.6) and C-reactive protein (CRP) >21.6mg/L (OR: 9.3; 95% CI 1.1-27.8), had a greater chance of achieving this outcome. Conclusion: Advanced cancer patients who underwent chemotherapy in less than 30 days before admission and who had diabetes mellitus were more likely to develop Coronavirus 2019 disease. Among the confirmed cases, those hospitalized with worse KPS and bigger CRP were more likely to die.


  • Prognostic assessment in palliative cancer care: is there a difference between adult and older patients?

    by Simone Garruth dos Santos Machado Sampaio, Livia Costa Oliveira, Karla Santos da Costa Rosa

    OBJECTIVE: To compare factors associated with death in adults and older people with advanced cancer who were hospitalized in a palliative care unit (PCU). METHODS: Case-control study with patients (adults vs older people) admitted to a PCU of National Cancer Institute José Alencar Gomes da Silva (INCA), in Rio de Janeiro, Brazil. Logistic regressions (odds ratio [OR] and 95% confidence interval [95%CI]) were used to identify factors associated with death. RESULTS: The study included 205 patients, most of which were aged over 60 years old (60.5%). Among the adult patients, a Karnofsky Performance Status ≤ 40% (OR 2.54 [95%CI 1.11–3.45]) and neutrophil-to-lymphocyte ratio (NLR) (OR 1.09 [95%CI 1.02–1.24]) were risk factors for death, while albumin (OR 0.30 [95%CI 0.12–0.78]) was a protective factor. Among older patients, NLR (OR: 1.13 [95%CI 1.02–1.24]), C-reactive protein (CRP) (OR 1.09 [95%CI 1.02–1.17]), modified Glasgow Prognostic Score (mGPS) 1 and 2 (OR 4.66 [95%CI 1.35–16.06]), CRP-to-albumin ratio (CAR) (OR 1.27 [95%CI 1.03–1.58]), and nutritional risk (OR 1.11 [95%CI 1.03–1.19]) were risk factors, whereas albumin (OR 0.23 [95%CI 0.09–0.57]) was a protective factor against death. CONCLUSIONS: Prognostic factors differed between groups. The NLR was a risk factor, and albumin was a protective factor regarding death in both groups. Additionally, CRP, mGPS, CAR, and nutritional risk were associated with an increased risk of death only among older people.